Skip to main
PRE

PRE Stock Forecast & Price Target

PRE Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Prenetics Global is positioned for continued growth in the consumer health and wellness market due to its scientifically backed products, diverse product line, and focus on customer retention. With a successful track record of increasing customer AOV and subscription rates, along with strategic efforts to increase profitability, Prenetics Global's stock is expected to continue its upward trend. The company's strong leadership team and expansion plans will also contribute to its positive outlook, with potential for further partnerships and product development.

Bears say

Prenetics Global is facing potential profitability challenges as it balances growth with expense management. The company's reliance on sales and marketing to acquire customers at a high cost and its transition to longer-duration subscribers may result in higher customer acquisition costs that could outweigh improvements in customer retention and lifetime value. Additionally, global shipping costs present a significant financial burden for the direct-to-consumer brand.

PRE has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Prenetics Global Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Prenetics Global Ltd (PRE) Forecast

Analysts have given PRE a Strong Buy based on their latest research and market trends.

According to 5 analysts, PRE has a Strong Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $35.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $35.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Prenetics Global Ltd (PRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.